Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-06 2:09 pm Purchase |
2025-02-28 | 13G | Neurocrine Biosciences, Inc. NBIX |
The Vanguard Group | 10,129,687 10.150% |
419,359 (+4.32%) |
Filing History |
| 2025-02-05 06:50 am Sale |
2024-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
STATE STREET CORP STT |
4,891,137 4.800% |
-257,156 (-4.99%) |
Filing History |
| 2024-10-17 09:54 am Purchase |
2024-09-30 | 13G | Neurocrine Biosciences, Inc. NBIX |
STATE STREET CORP STT |
5,148,293 5.100% |
5,148,293 (New Position) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Neurocrine Biosciences, Inc. NBIX |
The Vanguard Group | 9,710,328 9.880% |
370,033 (+3.96%) |
Filing History |
| 2024-01-23 11:52 am Purchase |
2023-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
BLACKROCK INC BLK |
13,647,679 13.900% |
1,020,276 (+8.08%) |
Filing History |
| 2023-02-24 06:15 am Purchase |
2023-02-23 | 13D | Voyager Therapeutics, Inc. VYGR |
NEUROCRINE BIOSCIENCES INC NBIX |
8,575,316 19.900% |
4,395,588 (+105.16%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Neurocrine Biosciences, Inc. NBIX |
The Vanguard Group | 9,340,295 9.720% |
552,304 (+6.28%) |
Filing History |
| 2023-02-09 11:05 am Sale |
2022-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
2,415,638 2.500% |
-5,030,201 (-67.56%) |
Filing History |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
BLACKROCK INC BLK |
12,627,403 13.100% |
1,150,858 (+10.03%) |
Filing History |
| 2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
PRICE T ROWE ASSOCIATES INC | 4,359,645 4.500% |
-1,912,085 (-30.49%) |
Filing History |
| 2022-02-10 4:46 pm Sale |
2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
7,445,839 7.800% |
-1,998,282 (-21.16%) |
Filing History |
| 2022-02-10 08:27 am Purchase |
2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
The Vanguard Group | 8,787,991 9.260% |
450,726 (+5.41%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
BLACKROCK INC BLK |
11,476,545 12.100% |
0 (Unchanged) |
Filing History |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
BLACKROCK INC BLK |
11,476,545 12.100% |
486,899 (+4.43%) |
Filing History |
| 2021-08-10 10:33 am Sale |
2021-08-09 | 13G | Neurocrine Biosciences, Inc. NBIX |
FMR CORP | 3,780,076 3.994% |
-4,656,553 (-55.19%) |
Filing History |
| 2021-04-12 2:46 pm Purchase |
2021-03-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
9,444,121 10.000% |
136,201 (+1.46%) |
Filing History |
| 2021-04-09 6:00 pm Purchase |
2021-03-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
BLACKROCK INC BLK |
10,989,646 11.700% |
3,991,851 (+57.04%) |
Filing History |
| 2021-02-16 4:04 pm Sale |
2021-02-16 | 13G | Neurocrine Biosciences, Inc. NBIX |
Capital International Investors | 4,049,442 4.300% |
-2,690,977 (-39.92%) |
Filing History |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
PRICE T ROWE ASSOCIATES INC | 6,271,730 6.700% |
-1,019,567 (-13.98%) |
Filing History |
| 2021-02-11 4:55 pm Purchase |
2020-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
9,307,920 9.900% |
1,934,408 (+26.23%) |
Filing History |